Early Detection Of Renal Injury
$636,575ZIAFY2023DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Paper 36869703Paper 36757801Paper 34097506Paper 34038674Paper 34035881Paper 33651717Paper 32778536Paper 32671344Paper 30663113Paper 29391006Paper 29117994Paper 28748478Paper 28724791Paper 28369995Paper 28057185Paper 27605421Paper 27341750Paper 27018079Paper 26994575Paper 26595535Paper 25186296Paper 25143457Paper 25052492Paper 24837807Paper 23925546Paper 23761678Paper 22442185Paper 22442182Paper 20407943Paper 20130532Paper 20032962Paper 19627513Paper 19389851Paper 19056867Paper 18509321Paper 18370314Paper 18280515Paper 16849569Paper 16760904Paper 16543755Paper 15882259Paper 15332261Paper 15213255Paper 15126607Paper 15086479Paper 14694173Paper 14523962Paper 13129410Paper 12886773Paper 12874475Paper 12643749Paper 12543772Paper 12028438Paper 11150816
Abstract
1) We are continuing our work on exosomes as a source of biomarkers, including proteins and miRNA. We are exploring proper normalizing techniques for these biomarkers, including counting exosomes by Nanosight Tracking Analysis. We are also exploring subsets of urine exosomes that may derive from different segments fo the nephron. 3) We are continuing our collaboration with HESI on miRNA biomarkers for kidney and liver toxicity. 4) We are continuing our work on sepsis and sepsis-AKI with two new biomarkers, one for each. 5) We are continuing our collaboration to look at two related biomarkers that can be elevated in the plasma of COVID-19 patients.
View original record on NIH RePORTER →